Gmt Capital Corp Annexon, Inc. Transaction History
Gmt Capital Corp
- $2.49 Billion
- Q1 2024
A detailed history of Gmt Capital Corp transactions in Annexon, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 2,645,524 shares of ANNX stock, worth $12.8 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
2,645,524
Previous 3,020,474
12.41%
Holding current value
$12.8 Million
Previous $13.7 Million
38.33%
% of portfolio
0.76%
Previous 0.53%
Shares
5 transactions
Others Institutions Holding ANNX
# of Institutions
138Shares Held
87.3MCall Options Held
2.54MPut Options Held
556K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.7MShares$42 Million9.43% of portfolio
-
Satter Management Co., L.P.7.41MShares$35.8 Million59.29% of portfolio
-
Bvf Inc San Francisco, CA7MShares$33.8 Million1.5% of portfolio
-
Redmile Group, LLC San Francisco, CA5.5MShares$26.6 Million1.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.16MShares$24.9 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $230M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...